Bilateral Implantation of a New Refractive Multi-Segmented M
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
A Study was conducted to evaluate the safety and efficacy of a new multi-segmented refractive multifocal intraocular lens (IOL) after phacoemulsification and refractive lens exchange (RLE) that gave successful results.

In this prospective, multicenter clinical trial, 63 presbyopic subjects who had cataract or where RLE candidates were bilaterally implanted with the Precizon Presbyopia IOL after phacoemulsification. Subjects were evaluated at baseline and at 1 day, 1 week, 1 and 3 months postoperatively for monocular and binocular uncorrected (UDVA) and corrected distance visual acuity (CDVA), uncorrected (UIVA) and distance-corrected intermediate visual acuity (DCIVA), uncorrected (UNVA), corrected (CNVA) and distance-corrected near visual acuity (DCNVA), contrast sensitivity and quality of vision.

Results:
--3 months postoperatively, binocular UDVA and CDVA of more than 20/40 was achieved in 98.4% (60/61) and 100%, respectively.

--Binocular UIVA and DCIVA of more 20/40 was achieved in 96.7% (59/61) and 93.4% (57/61) respectively.

--Binocular UNVA, CNVA and DCNVA of more than 20/40 was achieved in 93.4%, 98.4% and 95% subjects, respectively.

--Complete spectacle independence was achieved in 80% (49/61) patients; 93% of patients reported that they were quite or very satisfied with the outcomes of the procedure.

Finally, Precizon Presbyopia IOL implantation is a secure and reliable procedure for presbyopic and cataract patients to achieve reasonable visual acuity at all distances.

Source: https://www.dovepress.com/bilateral-implantation-of-a-new-refractive-multi-segmented-multifocal--peer-reviewed-fulltext-article-OPTH
Like
Comment
Share